Killing the Golden Goose of U.S. Drug Innovation (Part II): Drug Pricing Myths

In the second of a two-part series, Mercedes Meyer of Banner Witcoff and Brandon Phemester of Novavax delve into the real reasons why medicine costs more in the U.S.

Find the full article here.

Paid registration is required to view.